Advertisement
Screener

ClearPoint Neuro, Inc. (CLPT) Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award

ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award

ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award of 56.53 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward · last filed 2026-03-17

  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2024-12-31 was 34.29K shares.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2024-09-30 was 0.00 shares.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2021-12-31 was 22.92K shares.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2025 was 56.53K shares, a 41.77% decline from fiscal 2024.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2024 was 97.09K shares, a 15.00% increase from fiscal 2023.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2023 was 84.43K shares, a 49.27% increase from fiscal 2022.
  • ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for fiscal 2022 was 56.56K shares, a 146.80% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 12 month
2025-12-3156.53K shares
10-K · filed 2026-03-17
2024-12-3134.29K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
34.29K shares
derived: sum of 2 quarters · filed 2025-02-26
97.09K shares
10-K · filed 2025-02-26
2024-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
62.80K shares
10-Q · filed 2024-11-07
2024-06-3062.80K shares
10-Q · filed 2024-08-07
2023-12-3184.43K shares
10-K · filed 2024-03-12
2022-12-3156.56K shares
10-K · filed 2023-03-01
2022-06-3026.35K shares
10-Q · filed 2022-11-08
2021-12-3122.92K shares
10-Q · filed 2022-05-11
22.92K shares
10-K · filed 2022-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
CARLSMED, INC. (CARL)United States$0.405B
Orthofix Medical Inc. (OFIX)$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Embecta Corp. (EMBC)United States$0.319B2.10